ENDPOINTS

Trump axes Moderna bird flu pact worth more than $750M

The Trump administration has killed an award worth $766 million to help Moderna ...

Trump axes Moderna bird flu pacts worth more than $750M

The Trump administration has killed two awards worth $766 million to help Modern...

Will the FDA approve Moderna's next-gen Covid shot?

After months of speculation, the US’ stance on Covid-19 vaccines under HHS chief...

Novo Nordisk ‘strongly’ urges US away from pharma tariffs

Novo Nordisk warned the US government not to impose pharma-specific tariffs, but...

Exclusive: Insurance startup Devoted Health cuts 5% of ...

Devoted Health, the Medicare Advantage insurer with a medical group, has laid of...

Insurance startup Devoted Health cuts 5% of workers in ...

Devoted Health, the Medicare Advantage insurer with a medical group, has laid of...

GSK, Spero report Phase 3 win for UTI antibiotic; Spero...

GSK and Spero Therapeutics announced that a Phase 3 trial for their complicated ...

Weeks after TIGIT fail, iTeos decides to wind down

Only fifteen days after saying it was searching for strategic alternatives, iTeo...

Veru’s obesity drug roughly as safe as Wegovy; Keros’ b...

Plus, news about Advanz, Alvotech and GeNeuro: Veru’s obesity drug generally...

Updated: MD Anderson-allied investment firm targets $25...

Headed into the biggest oncology research and development confab of the year, an...

Endpoints Livestream: Is the biotech market really as b...

Today on Post-Hoc Live, we’re going to take a deep dive into Founding Editor Joh...

#ASCO25: Strand Therapeutics reports promising start fo...

A Boston biotech with self-replicating mRNA technology has shared early data fro...

MD Anderson targets $250M for second cancer biotech fund

Headed into the biggest oncology research and development confab of the year, on...

InflaRx cans Gohibic development after skin disease tri...

InflaRx is to cease work on its intravenous complement inhibitor Gohibic for the...

Axsome and Hetero settle patent fight over sleep disord...

Hetero Labs could launch its generic sleep disorder drug as early as 2040 under ...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.